Lamotrigine is primarily used to treat seizures. According to IQVIA data, the estimated market size for the product is $27 million for the twelve months ending December 2025.
KSB shares have done well over the last 12 months, having gained over 30%, while those of Sanofi Consumer have been underperformers over the last six months.
LTIMindtree partners with NVIDIA to modernise CBDT’s Insight 2.0 tax analytics platform, deploying BlueVerse and AI for improved governance, compliance, and citizen services in India.
Dipan Mehta of Elixir Equities prefers pharma and specialty chemicals for medium-term investments, remains cautious on IT amid AI uncertainty, and suggests exiting Info Edge stock.
As of December 31, 2025, filings show that Block had a total of 10,205 employees, which will now be cut down to less than 6,000 after the layoffs.
Motilal Oswal expects Laurus Labs to end financial year 2026 with a Profit After Tax (PAT) of ₹850 crore and reach ₹1,150 crore by financial year 2028, implying a Compounded Annual Growth Rate (CAGR) of 16% by this period.
Market breadth on Wall Street was on the positive side on Thursday, as despite a 0.5% fall on the S&P 500, more than 350 of its constituents ended with gains.
Netflix shares surged in extended trading after it abandoned the deal with Warner Bros. Discovery, but the latter’s shares are trading with losses.
Bino Pathiparampil, Head of Research at Elara Securities believes the broader pharma space is entering a more favourable phase as pricing concerns and regulatory worries ease while currency movements provide an additional boost.
Brokerage firm Emkay Global said that generative AI is still some distance away from being enterprise-ready at scale and is unlikely to have universal applicability across use cases in the near term.